Aimovig and Requip drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aimovig and Requip. Common interactions include deep vein thrombosis among females and depression among males.

The phase IV clinical study analyzes what interactions people who take Aimovig and Requip have. It is created by eHealthMe based on reports of 19 people who take Aimovig and Requip from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

19 people who take Aimovig and Requip together, and have interactions are studied.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 38,221 Aimovig users for its effectiveness, alternative drugs and more.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,100 Requip users for its effectiveness, alternative drugs and more.

Number of Aimovig and Requip reports submitted per year:

Common Aimovig and Requip drug interactions by gender *:

female:

Deep vein thrombosis
Dyskinesia
Fatigue
Immunosuppression
Insomnia
Muscular weakness
Mycobacterial infection
Neck pain
Pruritus
Pyrexia

male:

Depression
Generalised anxiety disorder
Suicidal ideation

Common Aimovig and Requip drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Depression
Generalised anxiety disorder
Suicidal ideation

40-49:

Abnormal dreams
Alopecia
Anxiety
Arthralgia
Disability
Fatigue
Flushing
Headache
Hypoaesthesia
Lower limb fracture

50-59:

Nausea
Dizziness
Dysphonia
Fatigue
Immunosuppression
Insomnia
Joint stiffness
Multiple sclerosis
Multiple sclerosis relapse
Muscle spasms

60+:

Insomnia

Common conditions people have *:

Migraine (headache): 8 people, 42.11%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 36.84%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 36.84%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 10.53%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 10.53%
Diabetes: 2 people, 10.53%
Headache (pain in head): 2 people, 10.53%
Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 5.26%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 5.26%
Cough: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and Requip?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.